1 / 13

Medicines Optimisation

Medicines Optimisation. This meeting is organised and funded by Pfizer. UK/PHP/13/0087 May 2013. Agenda. Pfizer Healthy Partnerships and the Pharmacy Development Team Medicines Optimisation definition Patient outcomes 2012 campaign overview and results

talor
Télécharger la présentation

Medicines Optimisation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Medicines Optimisation This meeting is organised and funded by Pfizer UK/PHP/13/0087 May 2013

  2. Agenda • Pfizer Healthy Partnerships and the Pharmacy Development Team • Medicines Optimisation definition • Patient outcomes • 2012 campaign overview and results • Medicines Optimisation future developments

  3. Pharmacy Development Team: Strategy • Stand out as the leadership company for pharmacy for support, knowledge and collaboration • Demonstrate the value of pharmacy within the local and national healthcare environment • Continue partnering to deliver positive outcomes for pharmacy and Pfizer in reputation

  4. Improving quality, value and outcomes for patients from use of their medicines Higher level of engagement with patients and the public Breaking down barriers between the professions Incorporates concordance and adherence, more sophisticated than medicines management Medicines Optimisation - definition1 1. Keith Ridge; http://www.pjonline.com/news/straight_from_the_horse%E2%80%99s_mouth_%E2%80%94_medicines_optimisation_explained, March 2013 Dr Keith Ridge, Chief Pharmaceutical Officer England

  5. A challenge to measure Patient outcomes

  6. Medicines Optimisation Campaign (2012) 2 Launched to raise awareness: • Importance of taking medicines as prescribed • Benefits to patient health • Better value for NHS • Position community pharmacists as medicines experts • Encourage patient engagement with community pharmacy 2. Medicines Optimisation poster, Pfizer data on file Sept 2012

  7. Medicines Optimisation Campaign (2012) 2 Launched in two phases: • Pharmacy media and Consumer media • Print, online media, Pharmacy Show • Radio campaign • Posters • Access Pfizer 2. Medicines Optimisation poster, Pfizer data on file Sept 2012

  8. Regional versions (England) 3. Regional Medicines Optimisation posters, Pfizer, data on file Sept 2012

  9. Results 2 national consumer pieces 24 medical online & print articles 12 regional online newspapers 3,275,481 total reach 10 regional radio bulletins 48 social media posts 4. Data on file, Nov 2012

  10. Medicines Optimisation future developments: • Develop a better understanding of how Medicines Optimisation can be supported by the Professional Bodies and the ABPI • Develop a better understanding of how patient behaviour influences Medicines Optimisation • Develop a better understanding of how Medicines Optimisation can improve patient outcomes

  11. References • Keith Ridge interview, PJ online March 2013 http://www.pjonline.com/news/straight_from_the_horse%E2%80%99s_mouth_%E2%80%94_medicines_optimisation_explained • Medicines Optimisation poster (national), Sept 2012 • Medicines Optimisation posters (regional), Sept 2012 • Data on file, results of media campaign, Nov 2012 • Ref quoted re £300M: Evaluation of the Scale,Causes and Costs of Waste Medicines, York Health Econimics Consortium and School of Pharmacy, University of London, Nov 2010

More Related